Daniel H Bessesen MD

PubMed

• The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months : A Randomized Clinical Trial.
  Victoria A Catenacci, Danielle M Ostendorf, Zhaoxing Pan, Laura K Kaizer, Seth A Creasy
  Annals of Internal Medicine. 2025-04-01
• Use of Obesity Medications in the Era of GLP-1 Agonists: An Expert Panel Discussion.
  Jamy Ard, Lydia Alexander, Daniel Bessesen, Karlijn Burridge, Sean Hasan Hashmi
  The Permanente Journal. 2024-12-16
• 1 citations
  Molecular Transducers of Physical Activity Consortium (MoTrPAC): human studies design and protocol.
  , John M Jakicic, Wendy M Kohrt, Joseph A Houmard, Michael E Miller
  Journal of Applied Physiology. 2024-09-01

Lectures

• Obesity Therapeutics (Repeat) 
  ENDO 2019 - New Orleans, LA - 3/24/2019
• Patient-Centered Approaches to Long-Term Success in Weight Loss: “The time has come,” the Walrus said, “to talk of many things” 
  ENDO 2019 - New Orleans, LA - 3/23/2019
• Patient-Centered Approaches to Long-Term Success in Weight Loss: “The time has come,” the Walrus said, “to talk of many things” 
  ENDO 2019 - New Orleans, LA - 3/23/2019
• Obesity Therapeutics 
  ENDO 2019 - New Orleans, LA - 3/24/2019
• Debate: Energy Intake and Dietary Adherence are the Most Important Factors in Weight Loss 
  ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/20/2018
• Endocrine Board Review Course 2013 
  The Endocrine Society, New Orleans, Louisiana - 9/24/2013
• Clinical Diabetes and Endocrinology in 2013 
  National Jewish Health, Snowmass, Colorado - 1/19/2013
• Join now to see all